FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
UNIGENE LABORATORIES INC [ UGNE ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 06/03/2013 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Senior Secured Convertible Note | $0.09(1) | 06/03/2013 | A(2) | $500,000 | 06/03/2013 | 06/07/2013(3) | Common Stock | (1)(2) | (2) | $500,000 | I(4) | See Footnote(4) |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. Convertible, at the holder's option, into shares of common stock, par value $0.01 (the "Common Stock"), of Unigene Laboratories, Inc. (the "Issuer"). The conversion rate is calculated by dividing the sum of the principal to be converted, plus all accrued and unpaid interest thereon, by $0.09 per share of Common Stock, subject to adjustment as set forth in the senior secured convertible note. The senior secured convertible note provides for interest to be paid at a rate per annum equal to the greater of (i) the Prime Rate (as defined in the senior secured convertible note) plus 5% and (ii) 15% (the "Current Rate"). Due to a continuing default under that certain Amended and Restated Financing Agreement, dated as of March 16, 2010, by and among the Issuer, the parties thereto as "Lenders," and Victory Park Management, LLC, as administrative and collateral agent for the Lenders, the senior secured convertible note currently bears interest at a rate equal to the Current Rate plus 3%. |
2. On May 14, 2013, the Issuer used the proceeds from the sale of its interest in Nu-Co Development GmbH to repay an aggregate of $1,000,000 outstanding under notes held by the Lenders, as previously reported by the reporting persons. On June 3, 2013, VPC Fund II, L.P. ("VPC Onshore Fund") re-loaned $500,000 of such proceeds to the Issuer in exchange for the senior secured convertible note. |
3. The maturity date of the senior secured convertible note is the earlier of (i) June 7, 2013 and (ii) such earlier date as the unpaid principal balance of the senior secured convertible note becomes due and payable pursuant to the terms of the senior secured convertible note. |
4. Directly by VPC Onshore Fund and indirectly by (i) Victory Park GP II, LLC ("GP II"), as the general partner of VPC Onshore Fund, (ii) RNL VPC, LLC ("RNL VPC"), as the sole manager of GP II, (iii) Victory Park Capital Advisors, LLC ("Capital Advisors"), as the investment manager for VPC Onshore Fund, (iv) Jacob Capital, L.L.C. ("Jacob Capital"), as the sole manager of Capital Advisors, and (v) Richard Levy, as the sole member of Jacob Capital and the sole manager of RNL VPC. Each of GP II, RNL VPC, Capital Advisors, Jacob Capital and Richard Levy disclaims beneficial ownership of any of the reported securities except to the extent of its or his pecuniary interest therein. |
Remarks: |
See Exhibit 99.1 - Explanation of Responses See Exhibit 99.2 - Joint Filer Information |
/s/ Scott Zemnick, General Counsel | 06/05/2013 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |